SavedAdd your journal

Journals / Neurological sciences and neurophysiology (Online) / 2020 / Cilt: 37 - Sayı: 1

Validity and Reliability of the Turkish Version of the Mig‑Scog Scale in Migraine Patients

Burcu POLAT
Aynur ÖZGE
Nesrin HELVACI YILMAZ
Bahar TAŞDELEN
Özge ARICI DÜZ
Şeyma KILIÇ
SAYGIN SARI
Pages
29–35
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The factors of the instrument were evaluated as consistent (Cronbach’s alpha >0.60), and an overall Cronbach’s alpha of 0.8485 was calculated.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study assesses the validity and reliability of the Turkish version of the Mig‑SCog scale used to determine and monitor the cognitive functions of migraine patients during attacks.
📊
Key Findings & Data:Methods: After completion of the translation process, for this validity and reliability study the Mig‑SCog was administered to a total of 154 migraine patients (91 without aura, 32 with aura, and 31 chronic migraine patients) presenting to the Neurology Clinic of Istanbul Medipol University University.
💡
Conclusion & Impact:The factors of the instrument were evaluated as consistent (Cronbach’s alpha >0.60), and an overall Cronbach’s alpha of 0.8485 was calculated.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objectives: This study assesses the validity and reliability of the Turkish version of the Mig‑SCog scale used to determine and monitor the cognitive functions of migraine patients during attacks. Methods: After completion of the translation process, for this validity and reliability study the Mig‑SCog was administered to a total of 154 migraine patients (91 without aura, 32 with aura, and 31 chronic migraine patients) presenting to the Neurology Clinic of Istanbul Medipol University University. Internal consistency of the factors and the instrument as a whole were evaluated using Cronbach’s alpha coefficient and an alpha value >0.60 was considered acceptable. Results: As in the original, the result of factor analysis found a good fit for a 4‑factor structure of the Turkish version (KMO = 0.82 and Chi‑square P = 0.409), and the factor structure was similar to the original. The factors of the instrument were evaluated as consistent (Cronbach’s alpha >0.60), and an overall Cronbach’s alpha of 0.8485 was calculated. Conclusions: The Mig‑SCog showed sufficient validity and reliability to be used in Turkish society.

🔖

Cite This Article

POLAT, B., ÖZGE, A., YILMAZ, N. H., TAŞDELEN, B., DÜZ, Ö. A., KILIÇ, Ş., SARI, S. (2020). Validity and Reliability of the Turkish Version of the Mig‑Scog Scale in Migraine Patients. Neurological sciences and neurophysiology (Online), Cilt: 37 - Sayı: 1, 29–35. https://ajindex.com/articles/290608

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Burch RC, Loder S, Loder E, Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: Updated statistics from government health surveillance studies. Headache 2015;55:21‑34
  2. Ertas M, Baykan B, Orhan EK, Zarifoglu M, Karli N, Saip S, et al. One‑year prevalence and the impact of migraine and tension‑type headache in Turkey: A nationwide home‑based study in adults. J Headache Pain 2012;13:147‑57
  3. Gil‑Gouveia R, Oliveira AG, Martins IP. The impact of cognitive symptoms on migraine attack‑related disability. Cephalalgia 2016;36:422‑30
  4. Mulder EJ, Linssen WH, Passchier J, Orlebeke JF, de Geus EJ. Interictal and postictal cognitive changes in migraine. Cephalalgia 1999;19:557‑65
  5. Gil‑Gouveia R, Martins IP. Clinical description of attack‑related cognitive symptoms in migraine: A systematic review. Cephalalgia 2018;38:1335‑50
  6. Vuralli D, Ayata C, Bolay H. Cognitive dysfunction and migraine. J Headache Pain 2018;19:109
  7. Lee SH, Kang Y, Cho SJ. Subjective cognitive decline in patients with migraine and its relationship with depression, anxiety, and sleep quality. J Headache Pain 2017;18:77
  8. Gil‑Gouveia R, Oliveira AG, Martins IP. Subjective cognitive symptoms during a migraine attack: A prospective study of a clinic‑based sample. Pain Physician 2016;19:E137‑50
  9. Coppola G, Di Renzo A, Tinelli E, Di Lorenzo C, Di Lorenzo G, Parisi V, et al. Thalamo‑cortical network activity during spontaneous migraine attacks. Neurology 2016;87:2154‑60
  10. Gil‑Gouveia R, Oliveira AG, Martins IP. A subjective cognitive impairment scale for migraine attacks. The MIG‑SCOG: Development and validation. Cephalalgia 2011;31:984‑91
  11. Gil‑Gouveia R, Oliveira AG, Pavão Martins I. Clinical utility of the Mig‑SCog. Headache 2016;56:941‑51
  12. Farmer K, Cady R, Bleiberg J, Reeves D, Putnam G, O’Quinn S, et al. Sumatriptan nasal spray and cognitive function during migraine: Results of an open‑label study. Headache 2001;41:377‑84
  13. Farmer K, Cady R, Bleiberg J, Reeves D. A pilot study to measure cognitive efficiency during migraine. Headache 2000;40:657‑61
  14. Gil‑Gouveia R, Oliveira AG, Martins IP. Cognitive dysfunction during migraine attacks: A study on migraine without aura. Cephalalgia 2015;35:662‑74
  15. Gil‑Gouveia R, Oliveira AG, Martins IP. Assessment of cognitive dysfunction during migraine attacks: A systematic review. J Neurol 2015;262:654‑65
  16. Huang L, Juan Dong H, Wang X, Wang Y, Xiao Z. Duration and frequency o